Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction - Related Studies

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

This study is ongoing, but not recruiting participants.

Study NCT00030498. Last updated on November 22, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cancer

2	Interventions listed in this trial
		erlotinib hydrochloride

3	Additional drug interventions recognized in this trial
		Erlotinib

4	More general drug interventions related to this trial
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Protein Kinase Inhibitors

5	Sponsors listed in this trial
		Cancer and Leukemia Group B
		National Cancer Institute (NCI)